Vorchheimer D - Search Results

1

Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes.

Kronish IM, Rieckmann N, Halm EA, Shimbo D, Vorchheimer D, Haas DC, Davidson KW. Kronish IM, et al. Among authors: vorchheimer d. J Gen Intern Med. 2006 Nov;21(11):1178-83. doi: 10.1111/j.1525-1497.2006.00586.x. Epub 2006 Aug 9. J Gen Intern Med. 2006. PMID: 16899061 Free PMC article.

2

Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes.

Rieckmann N, Kronish IM, Haas D, Gerin W, Chaplin WF, Burg MM, Vorchheimer D, Davidson KW. Rieckmann N, et al. Among authors: vorchheimer d. Am Heart J. 2006 Nov;152(5):922-7. doi: 10.1016/j.ahj.2006.05.014. Am Heart J. 2006. PMID: 17070160

3

Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.

Davidson KW, Burg MM, Kronish IM, Shimbo D, Dettenborn L, Mehran R, Vorchheimer D, Clemow L, Schwartz JE, Lespérance F, Rieckmann N. Davidson KW, et al. Among authors: vorchheimer d. Arch Gen Psychiatry. 2010 May;67(5):480-8. doi: 10.1001/archgenpsychiatry.2010.36. Arch Gen Psychiatry. 2010. PMID: 20439829 Free PMC article.

4

The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, Guyatt GH, Mark DB, Harrington RA. Becker RC, et al. Among authors: vorchheimer da. Chest. 2008 Jun;133(6 Suppl):776S-814S. doi: 10.1378/chest.08-0685. Chest. 2008. PMID: 18574278

5

Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: initiate treatment early or wait for the catheterization laboratory?

Harnick DJ, Vorchheimer DA. Harnick DJ, et al. Among authors: vorchheimer da. Curr Cardiol Rep. 2001 Sep;3(5):355-61. doi: 10.1007/s11886-001-0051-8. Curr Cardiol Rep. 2001. PMID: 11504571 Review.

6

Platelets in atherothrombosis.

Vorchheimer DA, Becker R. Vorchheimer DA, et al. Mayo Clin Proc. 2006 Jan;81(1):59-68. doi: 10.4065/81.1.59. Mayo Clin Proc. 2006. PMID: 16438480 Review.

7

Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation.

Zafar MU, Santos-Gallego C, Vorchheimer DA, Viles-Gonzalez JF, Elmariah S, Giannarelli C, Sartori S, Small DS, Jakubowski JA, Fuster V, Badimon JJ. Zafar MU, et al. Among authors: vorchheimer da. J Thromb Haemost. 2013 Jan;11(1):100-6. doi: 10.1111/jth.12058. J Thromb Haemost. 2013. PMID: 23137352 Free PMC article. Clinical Trial.

8

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease.

Vorchheimer DA, Badimon JJ, Fuster V. Vorchheimer DA, et al. JAMA. 1999 Apr 21;281(15):1407-14. doi: 10.1001/jama.281.15.1407. JAMA. 1999. PMID: 10217057 Review.

9

Normalization of platelet reactivity in clopidogrel-treated subjects.

Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ. Vilahur G, et al. Among authors: vorchheimer da. J Thromb Haemost. 2007 Jan;5(1):82-90. doi: 10.1111/j.1538-7836.2006.02245.x. J Thromb Haemost. 2007. PMID: 17239165 Free article. Clinical Trial.

10

What is QT interval prolongation?

Vorchheimer DA. Vorchheimer DA. J Fam Pract. 2005 Jun;Suppl:S4-7. J Fam Pract. 2005. PMID: 15938992 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters